LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 3246

Search options

  1. Article: The Japanese Catheter Ablation Registry (J-AB): Annual report in 2021.

    Kusano, Kengo / Yamane, Teiichi / Inoue, Koichi / Takegami, Misa / Nakai, Michikazu / Kanaoka, Koshiro / Tonegawa-Kuji, Reina / Miyamoto, Koji / Iwasaki, Yu-Ki / Takatsuki, Seiji / Nakamura, Kohki / Iwanaga, Yoshitaka / Shimizu, Wataru

    Journal of arrhythmia

    2023  Volume 39, Issue 6, Page(s) 853–859

    Abstract: The Japanese Catheter Ablation (J-AB) registry, started in August 2017, is a voluntary, nationwide ...

    Abstract The Japanese Catheter Ablation (J-AB) registry, started in August 2017, is a voluntary, nationwide, multicenter, prospective, observational registry, performed by the Japanese Heart Rhythm Society (JHRS) in collaboration with the National Cerebral and Cardiovascular Center using a Research Electronic Data Capture system. The purpose of this registry is to collect the details of target arrhythmias, the ablation procedures, including the type of target arrhythmias, outcomes, and acute complications in the real-world settings. During the year of 2021, we have collected a total of 89 609 procedures (mean age of 66.1 years and 65.9% male) from 506 participant hospitals. Detailed data are shown in Figures and Tables.
    Language English
    Publishing date 2023-09-25
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 2696593-8
    ISSN 1883-2148 ; 1880-4276
    ISSN (online) 1883-2148
    ISSN 1880-4276
    DOI 10.1002/joa3.12931
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The Japanese Catheter Ablation Registry (J-AB): Annual report in 2020.

    Kusano, Kengo / Yamane, Teiichi / Inoue, Koichi / Takegami, Misa / Nakao, Yoko M / Nakai, Michikazu / Kanaoka, Koshiro / Tonegawa-Kuji, Reina / Miyamoto, Koji / Iwasaki, Yu-Ki / Takatsuki, Seiji / Nakamura, Kohki / Iwanaga, Yoshitaka / Shimizu, Wataru

    Journal of arrhythmia

    2022  Volume 38, Issue 5, Page(s) 675–681

    Abstract: The Japanese Catheter Ablation (J-AB) registry, started in August 2017, is a voluntary, nationwide ...

    Abstract The Japanese Catheter Ablation (J-AB) registry, started in August 2017, is a voluntary, nationwide, multicenter, prospective, observational registry, performed by the Japanese Heart Rhythm Society (JHRS) in collaboration with the National Cerebral and Cardiovascular Center using a Research Electronic Data Capture system. The purpose of this registry is to collect the details of target arrhythmias, the ablation procedures, including the type of target arrhythmias, outcomes, and acute complications in real-world settings. During the year 2020, we have collected a total of 84 591 procedures (mean age of 65.8 years and 66.6% male) from 466 participant hospitals. Detailed data were shown in Figures and Tables.
    Language English
    Publishing date 2022-08-27
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 2696593-8
    ISSN 1883-2148 ; 1880-4276
    ISSN (online) 1883-2148
    ISSN 1880-4276
    DOI 10.1002/joa3.12772
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination.

    Lescale, Chloé / Lenden Hasse, Hélène / Blackford, Andrew N / Balmus, Gabriel / Bianchi, Joy J / Yu, Wei / Bacoccina, Léa / Jarade, Angélique / Clouin, Christophe / Sivapalan, Rohan / Reina-San-Martin, Bernardo / Jackson, Stephen P / Deriano, Ludovic

    Cell reports

    2016  Volume 16, Issue 11, Page(s) 2967–2979

    Abstract: ... Here, we find that the functions of PAXX and XLF in V(D)J recombination are masked by redundant joining ... Additionally, we demonstrate that PAXX function in V(D)J recombination depends on its interaction with Ku ... with ATM and the RAG complex. Our findings illuminate the role of PAXX in V(D)J recombination and support ...

    Abstract Paralog of XRCC4 and XLF (PAXX) is a member of the XRCC4 superfamily and plays a role in nonhomologous end-joining (NHEJ), a DNA repair pathway critical for lymphocyte antigen receptor gene assembly. Here, we find that the functions of PAXX and XLF in V(D)J recombination are masked by redundant joining activities. Thus, combined PAXX and XLF deficiency leads to an inability to join RAG-cleaved DNA ends. Additionally, we demonstrate that PAXX function in V(D)J recombination depends on its interaction with Ku. Importantly, we show that, unlike XLF, the role of PAXX during the repair of DNA breaks does not overlap with ATM and the RAG complex. Our findings illuminate the role of PAXX in V(D)J recombination and support a model in which PAXX and XLF function during NHEJ repair of DNA breaks, whereas XLF, the RAG complex, and the ATM-dependent DNA damage response promote end joining by stabilizing DNA ends.
    MeSH term(s) Animals ; Ataxia Telangiectasia Mutated Proteins/metabolism ; B-Lymphocytes/metabolism ; CRISPR-Cas Systems/genetics ; DNA Damage ; DNA Repair ; DNA Repair Enzymes/metabolism ; DNA-Binding Proteins/chemistry ; DNA-Binding Proteins/metabolism ; Gene Deletion ; Gene Editing ; Gene Rearrangement, B-Lymphocyte ; Immunoglobulins/genetics ; Ku Autoantigen/metabolism ; Models, Biological ; Oncogene Proteins v-abl/metabolism ; Sequence Homology, Amino Acid ; V(D)J Recombination/genetics
    Chemical Substances DNA-Binding Proteins ; IgK ; Immunoglobulins ; Oncogene Proteins v-abl ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; Ku Autoantigen (EC 4.2.99.-) ; DNA Repair Enzymes (EC 6.5.1.-)
    Language English
    Publishing date 2016-09-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2016.08.069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effectiveness of the J-Tip Guidewire for Selective Biliary Cannulation Compared to Conventional Guidewires (The JANGLE Study).

    Tsuchiya, Takayoshi / Itoi, Takao / Maetani, Iruru / Shigoka, Hiroaki / Ikeuchi, Nobuhito / Umeda, Junko / Sofuni, Atsushi / Itokawa, Fumihide / Ishii, Kentaro / Kurihara, Toshio / Tsuji, Shujiro / Tanaka, Reina / Tonozuka, Ryosuke / Honjyo, Mitsuyoshi / Mukai, Shuntaro / Moriyasu, Fuminori

    Digestive diseases and sciences

    2015  Volume 60, Issue 8, Page(s) 2502–2508

    Abstract: ... according to the type of guidewire used.: Aims: We evaluated the effectiveness of the J-tip guidewire ... patients with a native papilla who required biliary cannulation. We allocated the patients to the J-tip ... guidewire or angled-tip guidewire groups (groups J and A, respectively). If biliary cannulation was not ...

    Abstract Background: Wire-guided cannulation has become a common biliary cannulation technique worldwide. Different guidewires with various tip shapes and materials have been reportedly used for wire-guided cannulation. However, there are apparently no studies reporting changes in the biliary cannulation rate according to the type of guidewire used.
    Aims: We evaluated the effectiveness of the J-tip guidewire for biliary cannulation.
    Methods: We conducted a prospective, multicenter, controlled study involving patients with a native papilla who required biliary cannulation. We allocated the patients to the J-tip guidewire or angled-tip guidewire groups (groups J and A, respectively). If biliary cannulation was not achieved within 10 min, the GW was changed and cannulation was continued.
    Results: Groups J and A consisted of 66 and 65 enrolled patients, respectively. The biliary cannulation rate with a single guidewire for the first 10 min was 84.8 % (56/66) for group J and 80.0 % (52/65) for group A. The final success rate for biliary cannulation was 100 % in both groups. The mean times necessary for biliary cannulation were 285.8 and 267.6 s in group J and group A, respectively. The incidence rates of complications (i.e., all mild pancreatitis) were 3.0 % (2/66) and 6.2 % (4/65) in group J and group A, respectively. The mean amylase concentrations were 168.0 and 297.7 IU/L in group J and group A, respectively. There were no significant differences in any results between both groups.
    Conclusion: The biliary cannulation rate of the J-tip guidewire was not significantly different from those of standard guidewires.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Biliary Tract Diseases/diagnosis ; Catheterization/instrumentation ; Cholangiopancreatography, Endoscopic Retrograde/instrumentation ; Equipment Design ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
    Language English
    Publishing date 2015-08
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-015-3658-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination

    Chloé Lescale / Hélène Lenden Hasse / Andrew N. Blackford / Gabriel Balmus / Joy J. Bianchi / Wei Yu / Léa Bacoccina / Angélique Jarade / Christophe Clouin / Rohan Sivapalan / Bernardo Reina-San-Martin / Stephen P. Jackson / Ludovic Deriano

    Cell Reports, Vol 16, Iss 11, Pp 2967-

    2016  Volume 2979

    Abstract: ... Here, we find that the functions of PAXX and XLF in V(D)J recombination are masked by redundant joining ... Additionally, we demonstrate that PAXX function in V(D)J recombination depends on its interaction with Ku ... with ATM and the RAG complex. Our findings illuminate the role of PAXX in V(D)J recombination and support ...

    Abstract Paralog of XRCC4 and XLF (PAXX) is a member of the XRCC4 superfamily and plays a role in nonhomologous end-joining (NHEJ), a DNA repair pathway critical for lymphocyte antigen receptor gene assembly. Here, we find that the functions of PAXX and XLF in V(D)J recombination are masked by redundant joining activities. Thus, combined PAXX and XLF deficiency leads to an inability to join RAG-cleaved DNA ends. Additionally, we demonstrate that PAXX function in V(D)J recombination depends on its interaction with Ku. Importantly, we show that, unlike XLF, the role of PAXX during the repair of DNA breaks does not overlap with ATM and the RAG complex. Our findings illuminate the role of PAXX in V(D)J recombination and support a model in which PAXX and XLF function during NHEJ repair of DNA breaks, whereas XLF, the RAG complex, and the ATM-dependent DNA damage response promote end joining by stabilizing DNA ends.
    Keywords V(D)J recombination ; DNA repair ; NHEJ ; PAXX ; XLF ; XRCC4 ; Biology (General) ; QH301-705.5
    Subject code 612
    Language English
    Publishing date 2016-09-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Los linajes Victoria y Yamagata de los virus gripales B, desconocidos y poco valorados.

    Reina, J

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2022  Volume 35, Issue 3, Page(s) 231–235

    Abstract: The influenza virus B belongs to the family Orthomyxoviriridae and to the genus Influenzavirus B. It has a negative RNA-type genome made up of about 14,648 nucleotides divided into eight different segments that encode about 11 proteins. Before 1980 all ... ...

    Title translation The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued.
    Abstract The influenza virus B belongs to the family Orthomyxoviriridae and to the genus Influenzavirus B. It has a negative RNA-type genome made up of about 14,648 nucleotides divided into eight different segments that encode about 11 proteins. Before 1980 all influenza B viruses belonged to a single genetic lineage; but in this year two antigenically and genetically distinct lineages emerged which were named B/Victoria/2/1987 and B/Yamagata/16/1988. Intralineage and interlineage genetic exchange processes have been demonstrated; The most frequent of them are those in which the Victoria lineage acquires genes from the Yamagata lineage. It has been proposed that the differences in the evolutionary dynamics of the two lineages are due to the different binding preferences of influenza hemagglutinin to the cellular receptor. The Victoria lineage has shown the ability to bind to cell receptors with sialic acid residues at the α-2,3 and α-2,6 positions; whereas the Yamagata lineage does so exclusively in the human α-2,6 positions of the respiratory tract. Low circulation in recent months may have contributed to the temporary elimination ("extinction") of the Yamagata lineage. Since 2017, almost all of the strains of this lineage belong to clade 3A, when previously multiple circulating clades were detected. Although this clade 3A is diverse at the genetic level and has acquired surrogate mutations in the hemagglutinin gene, these have not determined significant antigenic changes that have made it necessary to replace its antigenic component (B/Pukhet/3073/2013) in the influenza vaccine since 2015.
    MeSH term(s) Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinins ; Humans ; Influenza B virus/genetics ; Influenza Vaccines ; Influenza, Human/prevention & control ; Phylogeny
    Chemical Substances Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins ; Influenza Vaccines
    Language Spanish
    Publishing date 2022-02-18
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/159.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The new generation of messenger RNA (mRNA) vaccines against influenza.

    Reina, Jordi

    Enfermedades infecciosas y microbiologia clinica (English ed.)

    2022  Volume 41, Issue 5, Page(s) 301–304

    Abstract: Today there are multiple types of flu vaccines. The emergence of nucleic acid technology used in vaccines against SARS-CoV-2 suggests its future application against this infection. Against influenza, two types of vaccines have been developed based on ... ...

    Abstract Today there are multiple types of flu vaccines. The emergence of nucleic acid technology used in vaccines against SARS-CoV-2 suggests its future application against this infection. Against influenza, two types of vaccines have been developed based on messenger RNA (mRNA): conventional or non-replicative and self-amplifying or replicative (auRNA), both included in lipid nanoparticles. Animal studies carried out with the former have shown their strong capacity to induce Th-1 antibodies and cellular immunity against influenza haemagglutinin (HA) with few side effects. Human trials have shown 87% seroconversion and 100% seroprotection. The auRNA vaccines have obtained similar results in animals but at a concentration 64 times lower than the conventional one. Vaccines based on mRNA platforms meet the WHO requirements for next generation influenza vaccines.
    MeSH term(s) Animals ; Humans ; Influenza, Human/prevention & control ; Influenza Vaccines ; mRNA Vaccines ; COVID-19 Vaccines ; COVID-19/prevention & control ; SARS-CoV-2 ; RNA, Messenger/genetics
    Chemical Substances Influenza Vaccines ; mRNA Vaccines ; COVID-19 Vaccines ; RNA, Messenger
    Language English
    Publishing date 2022-07-26
    Publishing country Spain
    Document type Journal Article ; Review
    ISSN 2529-993X
    ISSN (online) 2529-993X
    DOI 10.1016/j.eimce.2022.07.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2.

    Reina, J

    Revista clinica espanola

    2021  Volume 222, Issue 2, Page(s) 91–92

    MeSH term(s) COVID-19 ; Humans ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Vaccination
    Chemical Substances Spike Glycoprotein, Coronavirus
    Language English
    Publishing date 2021-09-14
    Publishing country Spain
    Document type Editorial ; Comment
    ISSN 2254-8874
    ISSN (online) 2254-8874
    DOI 10.1016/j.rceng.2021.05.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Posible efecto del «pecado antigénico original» en la vacunación frente a las nuevas variantes del SARS-CoV-2.

    Reina, J

    Revista clinica espanola

    2021  Volume 222, Issue 2, Page(s) 91–92

    Title translation Possible effect of the "original antigenic sin" in vaccination against new variants of SARS-CoV-2.
    Language Spanish
    Publishing date 2021-06-05
    Publishing country Spain
    Document type Editorial
    ZDB-ID 123597-7
    ISSN 1578-1860 ; 0014-2565 ; 0014-2565
    ISSN (online) 1578-1860 ; 0014-2565
    ISSN 0014-2565
    DOI 10.1016/j.rce.2021.05.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Plitidepsina, un inhibidor del factor de elongación celular eEF1a y molnupiravir un análogo del ribonucleósido citidina, dos nuevos compuestos químicos con intensa actividad frente al SARS-CoV-2.

    Reina, J

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2021  Volume 34, Issue 5, Page(s) 402–407

    Abstract: The knowledge of the replicative cycle of SARS-CoV-2 and its interactions with cellular proteins has opened a new therapeutic possibility based on blocking those essential for the virus. The cellular protein elongation factor eEF1A could be a good target. ...

    Title translation Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2.
    Abstract The knowledge of the replicative cycle of SARS-CoV-2 and its interactions with cellular proteins has opened a new therapeutic possibility based on blocking those essential for the virus. The cellular protein elongation factor eEF1A could be a good target. Among its natural inhibitors are didemnins and their related chemical compounds such as plitidepsin. In human cell culture, this compound is capable of inhibiting the virus with a potency 27,5 times that of remdesivir. It must be administered intravenously. Of the ribonucleoside analogues, molnupiravir (MK-4483/EIDD-2801) (hydroxy-cytidine) determines a lethal mutagenesis on SARS-CoV-2. In animals, after oral administration, the pulmonary viral load decreases 25,000 times and when administered as prophylaxis, approximately 100,000 times. It prevents the transmission of the virus and eliminates its presence in the oropharynx. Both chemicals have started Phase I / II human clinical trials.
    MeSH term(s) Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19 ; Cytidine/analogs & derivatives ; Depsipeptides ; Humans ; Hydroxylamines ; Peptide Elongation Factors ; Peptides, Cyclic ; Ribonucleosides ; SARS-CoV-2
    Chemical Substances Antiviral Agents ; Depsipeptides ; Hydroxylamines ; Peptide Elongation Factors ; Peptides, Cyclic ; Ribonucleosides ; Cytidine (5CSZ8459RP) ; plitidepsin (Y76ID234HW) ; molnupiravir (YA84KI1VEW)
    Language Spanish
    Publishing date 2021-04-27
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/042.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top